Baidu
map

传染科

订阅

MedSci主页 / 所有栏目 / 传染科

口罩相关痤疮(maskne)和其它面部皮肤病

2021-06-09 MedSci原创 MedSci原创

皮肤病口罩Covid-19口罩相关痤疮(maskne)
关注

并不是所有与个人防护设备有关的面部皮肤病都是“maskne”。除了对皮肤状况进行标准的医疗治疗外，维护皮肤屏障和定期“摘口罩”是管理的重要方面

并不是所有与个人防护设备有关的面部皮肤病都是“maskne”。刺激性接触性皮炎是最常见的原因。除了对皮肤状况进行标准的医疗治疗外，维护皮肤屏障和定期“摘口罩”是管理的重要方面 covid-19大流行导致个人防护装备在医疗机构内外的使用显著增加。“maskne”一词在疫情期间变得越来越流行，特别是在媒体中，它被用来描述几种面部皮肤病。人们经常购买昂贵但可能无效的治疗方法来治疗这些疾病。 本文总结了与佩戴面部防护装备相关的最常见的面部皮疹原因，并强调了在评估因使用面部防护装备而出现新的或已存在的皮肤疾病恶化时需要注意的关键区域。 本文中的“面部防护装备”包括全面罩、护目镜、安全眼镜、外科口罩(FRSM IIR耐液体外科口罩)和呼吸器口罩(如FFP3、FFP2和N95)。 Maskne有多么普遍 与PPE相关的面部皮肤病已经得到了很好的描述，但关于其流行率的数据有限，而且通常使用描述性术语而不是具体诊断。根据有限的证据，与口罩相关的痤疮和刺激性接触性皮炎是与佩戴口罩相关的最常见面部皮肤疾病。 在covid-19大流行期间，一项对泰国833名医学院工作人员(包括医疗保健工作者和非医疗保健工作者

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826147, encodeId=f39b182614e7b, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 08 16:45:25 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006349, encodeId=4043100634903, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=525f1475783, createdName=raymond506, createdTime=Mon Aug 09 15:38:50 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307888, encodeId=b04a130e8888f, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Jun 11 13:45:25 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972518, encodeId=30489e251821, content=学习了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de061532678, createdName=rqxqq, createdTime=Thu Jun 10 15:17:11 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972506, encodeId=a5229e250677, content=好文章，学了很多知识！, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=ms2000000148435740, createdTime=Thu Jun 10 14:11:39 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2022-05-08 一叶知秋

    #皮肤病#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1826147, encodeId=f39b182614e7b, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 08 16:45:25 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006349, encodeId=4043100634903, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=525f1475783, createdName=raymond506, createdTime=Mon Aug 09 15:38:50 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307888, encodeId=b04a130e8888f, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Jun 11 13:45:25 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972518, encodeId=30489e251821, content=学习了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de061532678, createdName=rqxqq, createdTime=Thu Jun 10 15:17:11 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972506, encodeId=a5229e250677, content=好文章，学了很多知识！, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=ms2000000148435740, createdTime=Thu Jun 10 14:11:39 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-08-09 raymond506

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1826147, encodeId=f39b182614e7b, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 08 16:45:25 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006349, encodeId=4043100634903, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=525f1475783, createdName=raymond506, createdTime=Mon Aug 09 15:38:50 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307888, encodeId=b04a130e8888f, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Jun 11 13:45:25 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972518, encodeId=30489e251821, content=学习了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de061532678, createdName=rqxqq, createdTime=Thu Jun 10 15:17:11 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972506, encodeId=a5229e250677, content=好文章，学了很多知识！, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=ms2000000148435740, createdTime=Thu Jun 10 14:11:39 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-11 soongzhihua

    #口罩#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1826147, encodeId=f39b182614e7b, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 08 16:45:25 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006349, encodeId=4043100634903, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=525f1475783, createdName=raymond506, createdTime=Mon Aug 09 15:38:50 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307888, encodeId=b04a130e8888f, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Jun 11 13:45:25 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972518, encodeId=30489e251821, content=学习了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de061532678, createdName=rqxqq, createdTime=Thu Jun 10 15:17:11 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972506, encodeId=a5229e250677, content=好文章，学了很多知识！, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=ms2000000148435740, createdTime=Thu Jun 10 14:11:39 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 rqxqq

    学习了！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1826147, encodeId=f39b182614e7b, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun May 08 16:45:25 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006349, encodeId=4043100634903, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=525f1475783, createdName=raymond506, createdTime=Mon Aug 09 15:38:50 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307888, encodeId=b04a130e8888f, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Jun 11 13:45:25 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972518, encodeId=30489e251821, content=学习了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de061532678, createdName=rqxqq, createdTime=Thu Jun 10 15:17:11 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972506, encodeId=a5229e250677, content=好文章，学了很多知识！, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=ms2000000148435740, createdTime=Thu Jun 10 14:11:39 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 ms2000000148435740

    好文章，学了很多知识！

    0

相关资讯

口罩阻挡了病毒，也在引发皮肤疾病

皮肤也需要“劳逸结合，张弛有道”。

皮肤病患者预防新型冠状病毒肺炎个人防护专家共识（第一版）

2019年12月以来，湖北省武汉市陆续出现新型冠状病毒感染引起的以肺部病变为主的新发呼吸道传染病，即新型冠状病毒肺炎（Coronavirus disease 2019，COVID-19），之后呈现快速蔓延。该病具有发病迅速、传染性强、病程变化快等特点，因此采取甲类传染病的预防、控制措施。当前全国正处于新型冠状病毒肺炎防控工作的紧张阶段，皮肤病患者多存在皮肤屏障功能受损情况，会增加易感性。因此，皮肤

英国NICE发布了新型冠状病毒COVID-19管理指南：针对囊性纤维化、慢性阻塞性肺病和需要使用会影响免疫系统药物的皮肤病患者

COVID-19快速指南：囊性纤维化患者、慢性阻塞性肺部疾病患者、需要使用会影响免疫系统药物的皮肤病患者

Arthritis Rheumatol：抗中性粒细胞胞浆抗体相关性血管炎的皮肤表现

皮肤表现在AAV中很常见且有差异。在GAV、EGPA、胞浆/抗PR3 ANCA阳性或ANCA阴性患者中，皮肤表现与疾病严重程度相关。

紫外线治疗皮肤病临床应用专家共识

紫外线在银屑病、白癜风、皮肤淋巴瘤、特应性皮炎等皮肤病治疗中具有重要地位。近年来随着光医学技术的发展，更加安全高效的紫外线治疗技术在皮肤病治疗中得到推广应用。为提高紫外线治疗的疗效与安全性，本共识对紫外线治疗在皮肤科的临床规范应用提出具体建议，供临床医生在实践中参考。

8款仿制药通过一致性评价！2款为首家过评，3款为第2家过评

11月4日，国家药监局官网显示8款仿制药通过/视同通过一致性评价，其中包括2款为国内首家过评，分别为江西亿友药业的吡拉西坦片和青峰药业的拉考沙胺注射液；以及3款国内第2家过评，分别为扬子江的注射用泮托

Baidu
map
Baidu
map
Baidu
map